pharmaceutical investing Ascendis Pharma Files Investigational New Drug Application for Phase 2 Trial of TransCon
Ascendis Pharma Announces Orphan Drug Designation Granted for TransCon PTH as Treatment for Hypoparathyroidism
Providence Gold Mines Inc. Receives Regulatory Approvals for Fundamental Transaction & The La Dama de Oro Gold Property NI 43-101 Report
CHARBONE Announces the Reception of the Main Components at the Sorel-Tracy Site and the Launch of Civil Works
CHARBONE annonce la reception des principales composantes sur le site de Sorel-Tracy et le lancement des travaux civils
